Senores Pharmaceuticals Limited has informed both BSE Limited and the National Stock Exchange of India (NSE) about the closure of its trading window for all designated persons, directors, promoters, and their immediate relatives. The closure period will be effective from April 1, 2025, and will remain in place until 48 hours after the announcement of the audited financial results for the quarter and year ending March 31, 2025.

Trading Window Closure Details

As per the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s Code of Conduct for Prevention of Insider Trading, the trading window is being closed to ensure compliance with insider trading regulations. During this period, all directors, promoters, designated persons, and their immediate relatives are prohibited from trading in the company’s securities.

The closure period starts on April 1, 2025, and will last until 48 hours after the declaration of the audited financial results for the quarter and year ending March 31, 2025.

Compliance with Insider Trading Regulations

The closure of the trading window ensures compliance with the SEBI PIT (Prohibition of Insider Trading) Regulations, which are designed to prevent the misuse of unpublished price-sensitive information (UPSI). These regulations require companies to maintain strict controls on trading during periods when sensitive information is being discussed internally but has not yet been made public.

Insider trading violations are considered severe offenses, and this move helps safeguard the integrity of the market by ensuring that no individual gains an unfair advantage.

Who is Affected During the Trading Window Closure?

The closure of the trading window applies to the following individuals:

• Directors

• Promoters

• Designated Persons, including employees who may have access to insider information

• Immediate Relatives of the above-mentioned categories

Reopening of Trading Window

The trading window will be reopened 48 hours after the announcement of the audited financial results for the quarter and year ending March 31, 2025. This period ensures that no individual can use sensitive financial information for personal gain before it becomes publicly available.

Date of Board Meeting to Approve Financial Results

The Board Meeting to approve the audited financial results for the quarter and year ending March 31, 2025 will be announced separately in due course. This will provide a clear timeline for when trading activities can resume.

Key Dates:

• Trading Window Closure Date: April 1, 2025

• Reopening of Trading Window: 48 hours after the declaration of the audited financial results

Importance of Trading Window Closure

The closure of the trading window is a crucial compliance measure. By restricting trading during this period, the company ensures that insiders cannot capitalize on sensitive, non-public information, protecting both shareholder interests and the market’s integrity.

Conclusion

Senores Pharmaceuticals Limited has announced the closure of its trading window starting from April 1, 2025, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s Code of Conduct for Prevention of Insider Trading. This period will last until 48 hours after the declaration of the audited financial results for the quarter and year ending March 31, 2025. The company is committed to ensuring the highest standards of corporate governance and protecting its stakeholders from the misuse of sensitive financial information. The date for the Board Meeting to approve the financial results will be communicated separately.

The Upcoming IPOs in this week and coming weeks are Arisinfra Solutions Limited, Infonative Solutions Limited,Spinaroo Commercial Limited,Aten Papers & Foam Limited.

The Current active IPO are Retaggio Industries Limited,Identixweb Limited, ATC Energies System Limited, Shri Ahimsa Naturals Limited.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.